Organogenesis Holdings (ORGO) Gross Profit (2017 - 2026)

Organogenesis Holdings' Gross Profit history runs 10 years deep, the most recent figure standing at $11.5 million for Q1 2026.

• In Q1 2026, Gross Profit fell 81.81% year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $336.9 million (down 3.2% YoY), while the FY2025 annual figure was $426.6 million, up 16.47% from the prior year.
• Gross Profit was $11.5 million for Q1 2026 at Organogenesis Holdings, down from $175.7 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $175.7 million in Q4 2025 to a low of $11.5 million in Q1 2026.
• Historically, Gross Profit has averaged $84.6 million across 5 years, with a median of $88.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Gross Profit surged 83.77% in 2025, then slumped 81.81% in 2026.
• A 5-year view of Gross Profit shows it stood at $88.4 million in 2022, then dropped by 18.69% to $71.9 million in 2023, then soared by 33.0% to $95.6 million in 2024, then soared by 83.77% to $175.7 million in 2025, then tumbled by 93.48% to $11.5 million in 2026.
• The last three Gross Profit figures came in at $11.5 million (Q1 2026), $175.7 million (Q4 2025), and $97.7 million (Q3 2025), per Business Quant data.